Slowing of number naming speed by King-Devick test in Parkinson's disease.

Slowing of number naming speed by King-Devick test in Parkinson's disease.
复制标题

King-Devick 测试在帕金森病中减缓数字命名速度。

DOI:
10.1016/j.parkreldis.2013.10.009
复制
发表时间:
2014
影响因子:
4.1
通讯作者:
Devick,Steve
Devick,Steve
中科院分区:
医学2区
文献类型:
--
作者:
Lin,TanyaP;Adler,CharlesH;Hentz,JosephG;Balcer,LauraJ;Galetta,StevenL;Devick,Steve

文献摘要

被引文献

相似文献

背景King-Devick(KD)测试测量快速数字命名的速度,并且被假定需要快速眼动、注意力、语言以及可能的认知功能的其他方面。虽然在多个运动脑震荡的研究中使用,它还没有被应用到该领域的运动disorders. MethodsForty 5帕金森氏病(PD),23原发性震颤(ET),和65个对照组进行了研究。受试者进行了两个试验的阅读大声的个位数分开的不同间距的三个测试卡是不同的格式。快速试验的总时间被指定为KD评分,并在三个groups.ResultsPD患者有更高(更差)KD评分,与ET和对照组相比,阅读时间更长(66秒对49秒对52秒,p< 0.001,调整年龄和性别)。ET组与对照组之间无显著性差异(Δ =-3s,95%CI:-10至4)。结论这是帕金森病King-Devick试验的首次研究。PD患者被发现有一个缓慢的快速数字命名速度相比,控制。这项测试可能是一个简单而快速的床边工具,用于量化帕金森病患者视觉和认知功能的相关性。
BackgroundThe King–Devick (KD) test measures the speed of rapid number naming, and is postulated to require fast eye movements, attention, language, and possibly other aspects of cognitive functions. While used in multiple sports concussion studies, it has not been applied to the field of movement disorders.MethodsForty-five Parkinson's disease (PD), 23 essential tremor (ET), and 65 control subjects were studied. Subjects performed two trials of reading out loud single-digit numbers separated by varying spacing on three test cards that were of different formats. The sum time of the faster trial was designated the KD score and compared across the three groups.ResultsPD patients had higher (worse) KD scores, with longer reading times compared to ET and control subjects (66 s vs. 49 s vs. 52 s,p< 0.001, adjusting for age and gender). No significant difference was found between ET and control (Δ = −3 s, 95% CI: −10 to 4).ConclusionsThis is the first study of the King–Devick Test in Parkinson's disease. PD patients were found to have a slower rapid number naming speed compared to controls. This test may be a simple and rapid bedside tool for quantifying correlates of visual and cognitive function in Parkinson's disease.